| PROD2_RAT |
Rattus norvegicus |
|
PROD2_RAT is differentially expressed in 27 experiments [25 up/22 dn]: 19 organism parts: kidney [2 up/0 dn], peritoneal fat [0 up/1 dn], ...; 2 disease states: normal [0 up/1 dn], breast cancer [1 up/0 dn], 2 cell types, 1 cell lines, 9 compound treatments and 7 other conditions. |
| PROD2_RAT, Prodh2 |
|
Prodh2 (Mus musculus)
PUT1 (Saccharomyces cerevisiae)
(Compare orthologs)
|
|
|
| Proline dehydrogenase, Proline oxidase |
|
|
| glutamate biosynthetic process, oxidation reduction, proline catabolic process, proline dehydrogenase activity |
|
|
|
Q2V057
|
|
|
|
ENSRNOG00000020900
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Kidney
|
Organism part |
|
|
None
|
Compound treatment |
|
|
Peritoneal fat
|
Organism part |
|
|
Dentate gyrus
|
Organism part |
|
|
Granule cell
|
Cell type |
|
|
Pyramidal neuron
|
Cell type |
|
|
Neurointermediate lobe
|
Organism part |
|
|
Hippocampus CA1
|
Organism part |
|
|
Paraventricular nucleus
|
Organism part |
|
|
Normal
|
Disease state |
|
|
Breast cancer
|
Disease state |
|
|
N-methyl-N-nitrosurea
|
Compound treatment |
|
|
Clofibrate
|
Compound treatment |
|
|
Technical replicate 1
|
Replicate |
|
|
Valproic acid
|
Compound treatment |
|
|
Cerebellum
|
Organism part |
|
|
Hippocampus
|
Organism part |
|
|
Toxic compound
|
Clinical treatment |
|
|
Heart
|
Organism part |
|
|
Biological replicate 3
|
Replicate |
|
|
SISA
|
Strain or line |
|
|
Pineal gland
|
Organism part |
|
|
Stomach wall smooth muscle
|
Organism part |
|
|
SconSa
|
Strain or line |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
SCN2.2
|
Cell line |
|
|
Sulphated cholecystokinin-8
|
Compound treatment |
|
|
Primary cortex neuron
|
Organism part |
|
|
Large intestine
|
Organism part |
|
|
17a-ethynylestradiol
|
Compound treatment |
|
|
Raphe magnus
|
Organism part |
|
|
Somatomotor cortex
|
Organism part |
|
|
Endothelial cell
|
Organism part |
|
|
Hippocampus CA3
|
Organism part |
|
|
Bis-(2-chloroethyl) sulfide
|
Compound treatment |
|
|
Control diet
|
Growth condition |
|
|
Vitamin A deficient diet
|
Growth condition |
|
|
Cornea
|
Organism part |
|
|
Pituitary gland
|
Organism part |
|
|
N-methylformamide
|
Compound treatment |
|
|
Systolic and diastolic dysfunc...
|
Test result |
|
|
Cigarette smoke
|
Compound treatment |
|
|
None
|
Clinical treatment |
|
|
Sham fracture
|
Injury |
|
|
|
|
|
Processing time: 0.052 secs.